Product
IBI133
1 clinical trial
1 indication
Indication
CarcinomaClinical trial
A Multicentre, Open-label, Phase 1/2 Study of IBI133 in Subjects With Unresectable, Locally Advanced or Metastatic Solid TumoursStatus: Recruiting, Estimated PCD: 2025-12-30